人工智能与结肠镜经验:两项随机试验的启示
本研究通过随机对照非劣效性试验(AID-2)比较10名经验不足的内镜医师(<2000例结肠镜)在CADe辅助与标准结肠镜下的腺瘤检出率(ADR),并事后与专家参与的AID-1试验数据合并分析。结果显示CADe组ADR显著高于对照组(53.3% vs 44.5%;RR 1.22;95%CI 1.04-1.40;非劣效p<0.01,优效p=0.02),且医师经验水平与ADR差异无关(RR 1.02;95%CI 0.89-1.16)。
要点
- CADe辅助可提高经验不足医师的腺瘤检出率(53.3% vs 44.5%)。
- CADe对小型和远端病变的检出也有提升,不增加非肿瘤性病变检出。
- 医师经验水平并非ADR差异的决定因素(RR 1.02)。
核心结论
- 在经验不足的内镜医师中,CADe辅助结肠镜可提高腺瘤检出率及相关息肉参数。
- 医师经验水平对ADR差异的影响较小。
研究设计与样本
- 前瞻性、随机对照非劣效性试验(AID-2),纳入10名经验不足内镜医师(<2000例结肠镜)。
- 连续纳入40-80岁受试者行筛查/监测/诊断性结肠镜,随机分组使用CADe(GI Genius)或对照。
- 事后将AID-2数据与既往AID-1试验(6名经验丰富内镜医师)数据合并分析。
主要发现
- 共660例患者(62.3±10岁;男女各330例),CADe组总体ADR为53.3%,对照组为44.5%(RR 1.22;95%CI 1.04-1.40;非劣效p<0.01,优效p=0.02)。
- 每例结肠镜腺瘤数量、小型和远端病变检出在CADe组有类似增加。
- 非肿瘤性病变检出无差异。
- 合并分析多因素显示CADe使用(RR 1.29;95%CI 1.16-1.42)和结肠镜指征与ADR差异相关,而检查者经验水平无关(RR 1.02;95%CI 0.89-1.16)。
关键数值与推荐
- 主要结局为经组织学证实的腺瘤检出率(ADR)。
- CADe组ADR 53.3% vs 对照组44.5%,RR 1.22(95%CI 1.04-1.40),非劣效p<0.01,优效p=0.02。
- 合并分析中CADe的RR 1.29(95%CI 1.16-1.42),经验水平的RR 1.02(95%CI 0.89-1.16)。
临床怎么用
- 对于经验不足的内镜医师,使用CADe辅助可提高结肠镜腺瘤检出率。
- 医师经验水平不应作为是否使用CADe的主要决定因素。
局限性
- 事后合并分析非预先设定,可能存在混杂。
- 非专家医师定义为<2000例结肠镜,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Artificial intelligence has been shown to increase adenoma detection rate (ADR) as the main surrogate outcome parameter of colonoscopy quality. To which extent this effect may be related to physician experience is not known. We performed a randomised trial with colonoscopists in their qualification period (AID-2) and compared these data with a previously published randomised trial in expert endoscopists (AID-1). METHODS: In this prospective, randomised controlled non-inferiority trial (AID-2), 10 non-expert endoscopists (<2000 colonoscopies) performed screening/surveillance/diagnostic colonoscopies in consecutive 40-80 year-old subjects using high-definition colonoscopy with or without a real-time deep-learning computer-aided detection (CADe) (GI Genius, Medtronic). The primary outcome was ADR in both groups with histology of resected lesions as reference. In a post-hoc analysis, data from this randomised controlled trial (RCT) were compared with data from the previous AID-1 RCT involving six experienced endoscopists in an otherwise similar setting. RESULTS: In 660 patients (62.3±10 years; men/women: 330/330) with equal distribution of study parameters, overall ADR was higher in the CADe than in the control group (53.3% vs 44.5%; relative risk (RR): 1.22; 95% CI: 1.04 to 1.40; p<0.01 for non-inferiority and p=0.02 for superiority). Similar increases were seen in adenoma numbers per colonoscopy and in small and distal lesions. No differences were observed with regards to detection of non-neoplastic lesions. When pooling these data with those from the AID-1 study, use of CADe (RR 1.29; 95% CI: 1.16 to 1.42) and colonoscopy indication, but not the level of examiner experience (RR 1.02; 95% CI: 0.89 to 1.16) were associated with ADR differences in a multivariate analysis. CONCLUSIONS: In less experienced examiners, CADe assistance during colonoscopy increased ADR and a number of related polyp parameters as compared with the control group. Experience appears to play a minor role as determining factor for ADR. TRIAL REGISTRATION NUMBER: NCT:04260321.
引用
- Repici A, Spadaccini M, Antonelli G, et al. Artificial intelligence and colonoscopy experience: lessons from two randomised trials. Gut. 2021. PMID: 34187845. doi:10.1136/gutjnl-2021-324471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。